Alteration of prb/p16/cdk4 regulation in human osteosarcoma

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 489-493

  Serena Benassi, M ^a   Molendini, Lara ^a   Gamberi, Gabriella ^a   Ragazzini, Paola ^a   Rosa Sollazzo, M ^a   Merli, Mara ^a   Asp, Julia ^a   Magagnoli, Giovanna ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; ONCOPROTEIN; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ARTICLE; BONE TUMOR; CHEMISTRY; DNA METHYLATION; FOLLOW UP; GENETICS; HUMAN; OSTEOSARCOMA; PATHOLOGY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE NEOPLASMS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA METHYLATION; FOLLOW-UP STUDIES; GENES, P16; HUMANS; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 0033595635     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991022)84:5<489::aid-ijc7>3.0.co;2-d     Document Type: Article

References (22)

1. BENASSI, M.S ., MOLENDINI, L ., GAMBERI, G ., SOLLAZZO, M.R ., RAGAZZINI, P ., MERLI, M ., MAGAGNOLI, G ., SANGIORGI, L ., BACCHIM, P ., BERTONI, F. and Pica, P ., Altered GI phase in osteosarcoma. Int. J. Cancer, 74, 518-522 (1997).
2. FANG, X ., JIN, X ., Xu, H.-J ., Liu, L ., PENG, H.-Q ., HOGG, D ., ROTH, J ., Yu, Y ., Xu, F ., BAST, R. and MILLIS, G ., Expression of p16 induces transcriptional down-regulation of the KB gene. Oncogene, 16, 1-8 (1998).
3. HERMAN, J ., JEN, J ., MERLO, A. and BAYLIN, S ., Hypermethylationassociated inactivation indicates a tumor suppressor role for p15INK4B1. Cancer Res ., 56, 722-727 (1996a).
4. HERMAN, J.G ., GRAFF, R ., MYOHANEN, S ., NELKIN, B.D. and BAYLIN, S.B ., Methylation-specific PCR: a novel PCR assay for methylation status of CpG island. Proc. not. Acad. Sei. (Wash.), 96, 9821-9826 (1996ft).
5. HUNTER, T. and PINES, J ., Cyclin and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 ( 1994).
6. KARPEH, M.S ., BRENNAN, M.F ., CANCE, W.G ., WOODRUFF, J.M ., POLLACK, D ., CASPER, E.S ., DUDAS, M.E ., LATRES, E ., DROBNJAK, M. and CORDONCARDO, C ., Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Brit. J. Cancer, 72, 986-991 (1995).
7. LUKAS, J ., PARRY, D ., AAGAARD, L ., MANN, D ., BARTKOVA, J ., STRAUSS, M ., PETERS, G. and BARTER, J ., Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature (Land.), 375, 503-506 (1995).
8. MAELANDSMO, G ., BERNER, J.-M ., FLORENES, V ., FORUS, A ., HOVIG, E ., FODSTAD, O. and MYKLEBOST, O ., Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Brit. J. Cancer, 72, 393-398(1995).
9. MAELANDSMO, G ., FLOREXES, V ., HOVIG, E ., OYJORD, T ., ENGEBRAATEN, O ., HOLM, R ., BORRESEN, A.-L. and FODSTAD, O ., Involvement of the pRb/p 161 cdk4/cyclin Dl pathway in the tumorigenesis of sporadic malignant melanomas. Brit. J. Cancer, 73, 909-916 (1996).
10. MARCHINI, S ., CODEGONI, A ., BONAZZI, C ., CHIARI, S. and BROGGINI, M ., Absence of deletions but frequent loss of expression of p16 ink4 in human ovarian tumours. Brit. J. Cancer, 76, 146-149 (1997).
11. MILLER, C ., ASLO, A ., CAMPBELL, M ., KAWAMATA, N ., LAMPKIN, B. and KOEFFLER, H ., Alterations of p15, p16, and p18 in osteosarcoma. Cancer Genet. Cytogenet ., 86, 136-142(1996).
12. NOBORI, T ., MIURA, K ., Wu, D ., Lois, A ., TAKABAYASUI, K. and CARSON, D ., Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature (Loud.), 368, 753-756 (1994).
13. OTTERSON, G ., KHLEIF, S ., CHEN, W ., COXON, A.B. and KAYE, F.J ., CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16ink4 protein induction by 5-aza-2' deoxycytidine. Oncogene, 11, 1211-1216(1995).
14. SAMBROOK, J ., FRITSCH, R.F. and MANIATIS, R ., Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
15. SCHAPIRO, I ., PARK, J ., EDWARDS, C ., MAO, L ., MERLO, A ., SIDRANSKY, D .,
16. EWEN, M. and ROLLINS, B ., Multiple mechanisms of p161NK4 inactivation in nonsmall cell lung cancer cell lines. Cancer Res ., 55, 6200-6209 (1995).
17. SERRANO, M ., HANNON, G. and BEACH, D ., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Land.), 366, 704-707 (1994).
18. SPILLARE, E ., OKAMOTO, A ., HAGIWARA, K ., DEMETRICK, D ., SERRANO, M ., BEACH, D. and HARRIS, C ., Suppression of growth m vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected pI6INK4. Mol. Carcinog ., 16, 53-60(1996).
19. TAKEUCHI, S ., BARTRAM, C ., SERIU, T ., MILLER, C ., TOBLER, A ., JANSSEN, J ., REITER, A ., LUDWIG, W ., ZIMMERMANN, M. and SCHWALLER, J ., Analysis of a family of cyclin-dependent kinase inhibitors: p16/MTS2/INK4B, pI6/MTSl/ INK4A and pi8 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755-760(1995).
20. TAM, S.W ., THEODORAS, A.M ., SHAY, J.W ., DRAETTA, G.F. and PAGANO, M ., Differential expression and regulation of cyclin Dl protein in normal and tumor human cells: association with cdk4 is required for cyclin Dl function in GI progression. Oncogene, 9, 2663-2674 (1994).
21. YEAGER, T ., STADLER, W ., BELAIR, C ., PUTHENVEETTIL, J ., OLOPADE, O. and REZNIKOFF, C., Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res.. 55, 493-197 (1995).
22. ZETTERBERG, A ., LARSSON, O. and WIMAN, K., What is the restriction point? Curr. Opin. Cell Biol, 7, 835-842 (1995).